A phase 1b clinical trial aimed to examine the tolerability and efficacy of NSI-189 was conducted in 2014 and the study paper is available recently for the exact study results. […]
The report of non-tyrosine kinase inhibitor market in oncology in the period of 2015 to 2025 was released early in April of this year. Some of the data mentioned in […]
Isotope labeling has been widely used in various studies and practice, much more attention is paid on its application and technology advancement, the disposal of the related waste is ignored. […]
A French company, Proveprep, produced bioactive homodimer by the way of synthesis, which was often made by in vivo methods involving complicated facilities and processes. The success of recombinant synthesis […]
Tyrosine Kinase Inhibitor Can Induced a Continuous Improving Effect on Idiopathic Pulmonary Fibrosis
The continuous effect of tyrosine kinase inhibitor on idiopathic pulmonary was newly found and the effect can last about two years to slow the progression of idiopathic pulmonary (IPF), which […]
A non-profit organization researched and developed the latest version of NMR technique for drug ingredients identification and function judgment, which has been used in the field with a good feedback. […]
A team of scientists takes advantage of nanoparticle and is developing a novel sunscreen with better skin protection character. And now the product design has been finished and the tests […]
Through several years’ design and trial, scientists from Singapore developed a new drug test tool which will involve less cost, while being more accurate and fast in getting result. The […]
Following the finding that antioxidants might make the tumor grow faster, a recent study found that antioxidants are potential to double the rate for the metastasis of melanoma. The study […]
On 7th, October, Nobel Prize in Chemistry was announced by the Royal Swedish Academy of Science and was gained by Tomas Lindahl, Paul Modrich and Aziz Sancar for their breakthrough […]